Cargando…
Effects of Combined Inorganic Nitrate and Nitrite Supplementation on Cardiorespiratory Fitness and Skeletal Muscle Oxidative Capacity in Type 2 Diabetes: A Pilot Randomized Controlled Trial
Nitric oxide (NO) stimulates mitochondrial biogenesis in skeletal muscle. However, NO metabolism is disrupted in individuals with type 2 diabetes mellitus (T2DM) potentially contributing to their decreased cardiorespiratory fitness (i.e., VO(2)max) and skeletal muscle oxidative capacity. We used a r...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654804/ https://www.ncbi.nlm.nih.gov/pubmed/36364742 http://dx.doi.org/10.3390/nu14214479 |
Sumario: | Nitric oxide (NO) stimulates mitochondrial biogenesis in skeletal muscle. However, NO metabolism is disrupted in individuals with type 2 diabetes mellitus (T2DM) potentially contributing to their decreased cardiorespiratory fitness (i.e., VO(2)max) and skeletal muscle oxidative capacity. We used a randomized, double-blind, placebo-controlled, 8-week trial with beetroot juice containing nitrate (NO(3)(−)) and nitrite (NO(2)(−)) (250 mg and 20 mg/day) to test potential benefits on VO(2)max and skeletal muscle oxidative capacity in T2DM. T2DM (N = 36, Age = 59 ± 9 years; BMI = 31.9 ± 5.0 kg/m(2)) and age- and BMI-matched non-diabetic controls (N = 15, Age = 60 ± 9 years; BMI = 29.5 ± 4.6 kg/m(2)) were studied. Mitochondrial respiratory capacity was assessed in muscle biopsies from a subgroup of T2DM and controls (N = 19 and N = 10, respectively). At baseline, T2DM had higher plasma NO(3)(−) (100%; p < 0.001) and lower plasma NO(2)(−) levels (−46.8%; p < 0.0001) than controls. VO(2)max was lower in T2DM (−26.4%; p < 0.001), as was maximal carbohydrate- and fatty acid-supported oxygen consumption in permeabilized muscle fibers (−26.1% and −25.5%, respectively; p < 0.05). NO(3)(−)/NO(2)(−) supplementation increased VO(2)max (5.3%; p < 0.01). Further, circulating NO(2)(−), but not NO(3)(−), positively correlated with VO(2)max after supplementation (R(2)= 0.40; p < 0.05). Within the NO(3)(−)/NO(2)(−) group, 42% of subjects presented improvements in both carbohydrate- and fatty acid-supported oxygen consumption in skeletal muscle (vs. 0% in placebo; p < 0.05). VO(2)max improvements in these individuals tended to be larger than in the rest of the NO(3)(−)/NO(2)(−) group (1.21 ± 0.51 mL/(kg*min) vs. 0.31 ± 0.10 mL/(kg*min); p = 0.09). NO(3)(−)/NO(2)(−) supplementation increases VO(2)max in T2DM individuals and improvements in skeletal muscle oxidative capacity appear to occur in those with more pronounced increases in VO(2)max. |
---|